OmniSeq New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More OmniSeq Receives New York State Approval for Cancer Genomic, Immune Profiling Test The Insight test, which detects genomic variants, signatures, and immune gene expression to inform cancer treatment, will now be available to patients in New York. OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer The Phase II trial will use OmniSeq's RNA-seq assay to determine whether patients should be treated with one of two agents combined with BMS' nivolumab. Breaking News Drugs to Treat Smoking Addiction Suggested by Multi-Ancestry Transcriptome-Wide Association Study Chromosome 22 Copy Number Variants Linked to Traits in General Population Unilabs, Ambry Genetics Partner to Market Research-Use Genomic Testing Services Internationally Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests PlumCare RWE Taps Lifebit to Scale Rady-Backed Newborn Sequencing Screening Program in Greece The Scan Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine. Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time. Study Questions Existence of Fetal Microbiome A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination. Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.